Literature DB >> 34201435

New Insights into Non-Dietary Treatment in Celiac Disease: Emerging Therapeutic Options.

Verónica Segura1, Ángela Ruiz-Carnicer1, Carolina Sousa1, María de Lourdes Moreno1.   

Abstract

To date, the only treatment for celiac disease (CD) consists of a strict lifelong gluten-free diet (GFD), which has numerous limitations in patients with CD. For this reason, dietary transgressions are frequent, implying intestinal damage and possible long-term complications. There is an unquestionable need for non-dietary alternatives to avoid damage by involuntary contamination or voluntary dietary transgressions. In recent years, different therapies and treatments for CD have been developed and studied based on the degradation of gluten in the intestinal lumen, regulation of the immune response, modulation of intestinal permeability, and induction of immunological tolerance. In this review, therapeutic lines for CD are evaluated with special emphasis on phase III and II clinical trials, some of which have promising results.

Entities:  

Keywords:  celiac disease; gliadin; gluten; gluten immunogenic peptides; gluten-free diet; non-dietary therapies

Year:  2021        PMID: 34201435     DOI: 10.3390/nu13072146

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  128 in total

1.  Larazotide acetate regulates epithelial tight junctions in vitro and in vivo.

Authors:  Shobha Gopalakrishnan; Malarvizhi Durai; Kelly Kitchens; Amir P Tamiz; Robert Somerville; Mark Ginski; Blake M Paterson; Joseph A Murray; Elena F Verdu; Sefik S Alkan; Niranjan B Pandey
Journal:  Peptides       Date:  2012-02-27       Impact factor: 3.750

Review 2.  Issues related to gluten-free diet in coeliac disease.

Authors:  Riccardo Troncone; Renata Auricchio; Viviana Granata
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2008-05       Impact factor: 4.294

3.  HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease.

Authors:  Stig Tollefsen; Helene Arentz-Hansen; Burkhard Fleckenstein; Oyvind Molberg; Melinda Ráki; William W Kwok; Günther Jung; Knut E A Lundin; Ludvig M Sollid
Journal:  J Clin Invest       Date:  2006-07-27       Impact factor: 14.808

4.  Rationally engineered prolyl endopeptidases from Sphingomonas capsulata with improved hydrolytic activity towards pathogenic peptides of celiac diseases.

Authors:  Bin Xiao; Chun Zhang; Xiaotong Song; Miao Wu; Jianping Mao; Rong Yu; Yongxiang Zheng
Journal:  Eur J Med Chem       Date:  2020-07-06       Impact factor: 6.514

Review 5.  Novel therapies for coeliac disease.

Authors:  L M Sollid; C Khosla
Journal:  J Intern Med       Date:  2011-06       Impact factor: 8.989

6.  European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders.

Authors:  Abdulbaqi Al-Toma; Umberto Volta; Renata Auricchio; Gemma Castillejo; David S Sanders; Christophe Cellier; Chris J Mulder; Knut E A Lundin
Journal:  United European Gastroenterol J       Date:  2019-04-13       Impact factor: 4.623

7.  Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease.

Authors:  C Mitea; R Havenaar; J Wouter Drijfhout; L Edens; L Dekking; F Koning
Journal:  Gut       Date:  2007-05-09       Impact factor: 23.059

8.  Negative predictive value of the repeated absence of gluten immunogenic peptides in the urine of treated celiac patients in predicting mucosal healing: new proposals for follow-up in celiac disease.

Authors:  Ángela Ruiz-Carnicer; Marta Garzón-Benavides; Blanca Fombuena; Verónica Segura; Francisco García-Fernández; Salvador Sobrino-Rodríguez; Lourdes Gómez-Izquierdo; Marcos A Montes-Cano; Alfonso Rodríguez-Herrera; Raquel Millán; María C Rico; Carmen González-Naranjo; Juan M Bozada-García; Jacobo Díaz; Cristóbal Coronel-Rodríguez; Beatriz Espín; Manuel Romero-Gómez; Ángel Cebolla; Carolina Sousa; Isabel Comino; Federico Argüelles; Ángeles Pizarro
Journal:  Am J Clin Nutr       Date:  2020-11-11       Impact factor: 7.045

Review 9.  Coeliac disease.

Authors:  Benjamin Lebwohl; David S Sanders; Peter H R Green
Journal:  Lancet       Date:  2017-07-28       Impact factor: 79.321

10.  Coeliac disease: factors affecting the transition and a practical tool for the transition to adult healthcare.

Authors:  Fabiana Zingone; Serana Massa; Basilio Malamisura; Pasquale Pisano; Carolina Ciacci
Journal:  United European Gastroenterol J       Date:  2018-07-03       Impact factor: 4.623

View more
  3 in total

1.  Purified Clinoptilolite-Tuff as an Efficient Sorbent for Gluten Derived from Food.

Authors:  Carmen Ranftler; Andreas Röhrich; Andreas Sparer; Cornelius Tschegg; Dietmar Nagl
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

Review 2.  Celiac Disease and Possible Dietary Interventions: From Enzymes and Probiotics to Postbiotics and Viruses.

Authors:  Sandip K Wagh; Karen M Lammers; Manohar V Padul; Alfonso Rodriguez-Herrera; Veronica I Dodero
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208

3.  Advances in Celiac Disease and Gluten-Free Diet.

Authors:  Isabel Comino; Carolina Sousa
Journal:  Nutrients       Date:  2022-01-28       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.